Análise do perfil de adesão medicamentosa de pessoas vivendo com HIV e AIDS no município de Florianópolis

Abstract

Technological advances in antiretroviral therapies and the policy of decentralizing the care of people infected with HIV have resulted in an increase in the prevalence of people living with the disease. Drug adherence is essential to prevent the development of resistant strains and clinical complications, promoting infection control. Recognizing this need for care and treatment adherence, Brazil has committed to the 90-90-90 target proposed by the Joint United Nations Programme on HIV/AIDS (UNAIDS) which provides for 90% of HIV/AIDS cases to be diagnosed, that 90% of these are undergoing treatment and of these 90% reach viral suppression. In 2015, a large-scale national study demonstrated viral suppression in about 85% of users undergoing drug treatment. Similar studies were not found in the South region or in the city. This dissertation aimed to carry out a cross-sectional study quantifying the prevalence of treatment adherence in the city of Florianópolis, examining its association with demographic aspects, health utilization and clinical characteristics. Based on the analysis of secondary data from national and municipal databases, the prevalence of adherence to ART was around 85%. White males, who were monitored at both levels of care, had greater adherence to treatment. Age and number of consultations were directly associated with adherence to ART. The process of decentralizing care to users living with HIV and AIDS is the path to more comprehensive care, but technical and ethical challenges still need to be faced. Professional qualification, correct referral with network articulation and attention to secrecy and confidentiality issues need to be reinforced in order to expand treatment adherence. Adherence to ART is an important indicator of the quality of care and can support the planning of actions to improve health care for people with HIV/AIDS.